TNF and cancer: The most important vaccine with anti-cancer activities is ADXS 11-001 (or ADXS-HPV, formerly known as Lovaxin-C), a therapeutic Listeria-based vaccine targeting an HPV E7 antigen (108, 109) and resulting a TNF-alpha (TNF-α) response and IL-2 production by DCs (110).